Dekhtyar Maria, Papp Kathryn V, Buckley Rachel, Jacobs Heidi I L, Schultz Aaron P, Johnson Keith A, Sperling Reisa A, Rentz Dorene M
Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States.
Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
Neuropsychologia. 2017 Jun;100:164-170. doi: 10.1016/j.neuropsychologia.2017.04.037. Epub 2017 May 1.
Age-related memory decline has been well-documented; however, some individuals reach their 8th-10th decade while maintaining strong memory performance.
To determine which demographic and biomarker factors differentiated top memory performers (aged 75+, top 20% for memory) from their peers and whether top memory performance was maintained over 3 years.
Clinically normal adults (n=125, CDR=0; age: 79.5±3.57 years) from the Harvard Aging Brain Study underwent cognitive testing and neuroimaging (amyloid PET, MRI) at baseline and 3-year follow-up. Participants were grouped into Optimal (n=25) vs. Typical (n=100) performers using performance on 3 challenging memory measures. Non-parametric tests were used to compare groups.
There were no differences in age, sex, or education between Optimal vs. Typical performers. The Optimal group performed better in Processing Speed (p=0.016) and Executive Functioning (p<0.001). Optimal performers had larger hippocampal volumes at baseline compared with Typical Performers (p=0.027) but no differences in amyloid burden (p=0.442). Twenty-three of the 25 Optimal performers had longitudinal data and16 maintained top memory performance while 7 declined. Non-Maintainers additionally declined in Executive Functioning but not Processing Speed. Longitudinally, there were no hippocampal volume differences between Maintainers and Non-Maintainers, however Non-Maintainers exhibited higher amyloid burden at baseline in contrast with Maintainers (p=0.008).
Excellent memory performance in late life does not guarantee protection against cognitive decline. Those who maintain an optimal memory into the 8th and 9th decades may have lower levels of AD pathology.
与年龄相关的记忆衰退已有充分记录;然而,一些人进入八九十岁时仍保持着较强的记忆表现。
确定哪些人口统计学和生物标志物因素能够区分记忆表现最佳者(75岁以上,记忆能力处于前20%)与同龄人,以及最佳记忆表现能否在3年中得以维持。
来自哈佛衰老大脑研究的临床正常成年人(n = 125,临床痴呆评定量表[CDR]=0;年龄:79.5±3.57岁)在基线期和3年随访时接受了认知测试和神经影像学检查(淀粉样蛋白正电子发射断层扫描[PET]、磁共振成像[MRI])。根据在3项具有挑战性的记忆测试中的表现,将参与者分为最佳表现组(n = 25)和典型表现组(n = 100)。使用非参数检验对两组进行比较。
最佳表现组和典型表现组在年龄、性别或教育程度方面没有差异。最佳表现组在处理速度(p = 0.016)和执行功能(p<0.001)方面表现更好。与典型表现者相比,最佳表现者在基线期的海马体积更大(p = 0.027),但淀粉样蛋白负荷没有差异(p = 0.442)。25名最佳表现者中有23名有纵向数据,其中16名保持了最佳记忆表现,7名出现衰退。记忆表现衰退者在执行功能方面进一步下降,但处理速度没有下降。纵向来看,记忆表现维持者和衰退者之间的海马体积没有差异,然而,与记忆表现维持者相比,记忆表现衰退者在基线期的淀粉样蛋白负荷更高(p = 0.008)。
晚年出色的记忆表现并不能保证预防认知衰退。那些在八九十岁时仍保持最佳记忆的人可能具有较低水平的阿尔茨海默病病理学特征。